Pelvic exenteration: Ten-year experience at the European Institute of Oncology in Milan

Gynecologic Oncology

Volumn 114, Issue 1, 2009, Pages 64-68

  Maggioni, Angelo ^a   Roviglione, Giovanni ^a   Landoni, Fabio ^a   Zanagnolo, Vanna ^a   Peiretti, Michele ^a   Colombo, Nicoletta ^a   Bocciolone, Luca ^a   Biffi, Roberto ^a   Minig, Lucas ^a   Morrow, C Paul ^b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cervical cancer; Gynecologic malignancies; Gynecologic surgery; Pelvic exenteration; Radical surgery

Indexed keywords

ANTINEOPLASTIC AGENT; MEDROXYPROGESTERONE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL COMPETENCE; ENDOMETRIUM CANCER; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; OVARY CANCER; OVERALL SURVIVAL; PATIENT SELECTION; PELVIS EXENTERATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; STOMACH FISTULA; STOMACH OBSTRUCTION; SURGICAL APPROACH; SURGICAL MORTALITY; URINARY TRACT DISEASE; UTERINE CERVIX CANCER; UTERUS SARCOMA; VAGINA CANCER; VULVA CANCER;

ADULT; AGED; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; ITALY; MIDDLE AGED; OVARIAN NEOPLASMS; PELVIC EXENTERATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; SURVIVORS; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 67349239896     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.029     Document Type: Article

References (54)

1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1 (1948) 177-183
2. Berek J.S., Howe C., Lagasse L.D., and Hacker N.F. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA. Gynecol. Oncol. 99 (2005) 153-159
3. Houvenaeghel G., Moutardier V., Karsenty G., Bladou F., Lelong B., Buttarelli M., et al. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients. Gynecol. Oncol. 92 (2004) 680-683
4. Kraybill W.B., Lopez M.J., and Bricker E.M. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis. Surg. Gynecol. Obstet. 166 (1988) 259-263
5. Soper J.T., Berchuck A., Creasman W.T., and Clarke-Pearson D.L. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol. Oncol. 35 (1989) 93-98
6. Bladou F., Houvenaeghel G., Delpero J.R., and Gue'rinel G. Incidence and management of major urinary complications after pelvic exenteration for gynecological malignancies. J. Surg. Oncol. 58 (1995) 91-96
7. Anthopoulos A.P., Manetta A., Larson J.E., et al. Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience. Gynecol. Oncol. 35 (1989) 219-223
8. Landoni F., Maneo A., Colombo A., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 (1997) 535-540
9. Symmonds R.E., Pratt J.H., and Webb M.J. Exenterative operations: experience with 198 patients. Am. J. Obstet. Gynecol. 121 (1975) 907-918
10. Rutledge F., Smith J., Wharton J., and O'Quinn A. Pelvic exenteration; analysis of 296 patients. Am. J. Obstet. Gynecol. 129 (1977) 881-892
11. Averette H., Lichtinger M., Sevin B., and Girtanner R. Pelvic exenteration: a 15 year experience in a general metropolitan hospital. Am. J. Obstet. Gynecol. 150 (1984) 179-184
12. Roberts W., Cavanagh D., Bryson P., Lyman G., and Hewitt S. Major morbidity after pelvic exenteration: a seven year experience. Obstet. Gynecol. 69 (1987) 617-621
13. Hatch K.D., Shingleton H.M., Soong S.J., Baker V.V., and Gelder M.S. Anterior pelvic exenteration. Gynecol. Oncol. 31 (1988) 205-216
14. Morley G., Hopkins M., Lindenauer S., and Roberts J. Pelvic exenteration, University of Michigan, 100 patients at 5 years. Obstet. Gynecol. 74 (1989) 934-943
15. Lawhead R., Clark D., Smith D., Pierce V., and Lewis J. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center Experience (1972-1981). Gynecol. Oncol. 33 (1989) 279-282
16. Shingleton H.M., Soong S.J., Gelder M.S., Hatch K.D., Baker V.V., and Austin J. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet. Gynecol. 73 (1989) 1027-1034
17. Hatch K.D., Gelder M.S., Soong S.J., Baker V.V., and Shingleton H.M. Pelvic exenteration with low rectal anastomosis: survival, complications, and prognostic factors. Gynecol. Oncol. 38 (1990) 462-467
18. Matthews C., Morris M., Burke T., Gershenson D., Wharton T., and Rutledge F. Pelvic exenteration in the elderly patient. Obstet. Gynecol. 79 (1992) 773-777
19. Magrina J., Stanhope R., and Weaver A. Pelvic exenterations: supralevator, infralevator, and with vulvectomy. Gynecol. Oncol. 64 (1997) 130-135
20. Hatch K.D., and Berek J.S. Pelvic exenteration. In: Berek J.S., and Hacker N.F. (Eds). Practical Gynecologic Oncology. 4th ed. (2005), Philadelphia' Lippincott Williams and Wilkins 801-816
21. Morris M., Alvarez R.D., Kinney W.K., and Wilson T.O. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol. Oncol. 60 (1996) 288-291
22. Franchi M., and Donadello N. Pelvic exenteration in gynecologic oncology. Eur. J. Gynaecol. Oncol. 15 (1994) 469-474
23. Miller B., Morris M., Rutledge F., Mitchell M., Atkinson N., and Burke T. Aborted exenterative procedures in recurrent cervical cancer. Gynecol. Oncol. 50 (1993) 94-99
24. Penalver M., Bejany D., Averette H., Donato D., Sevin B., and Suarez G. Continent urinary diversion in gynecologic oncology. Gynecol. Oncol. 34 (1989) 274-288
25. Ravitch M., and Steichen F. A stapling instrument for end-to-end inverting anastomoses in the gastrointestinal tract. Ann. Surg. 189 (1979) 791-797
26. Osbourne R., Murphy K., and De Petrillo A. Pelvic exenteration. Gynecologic Oncology (1991), Elsevier, New York 207
27. Hallbook O., Pahlman L., Krog M., Wexner S.D., and Sjodahl R. Randomized comparison of straight and colonic J pouch anastomosis after low anterior resection. Ann. Surg. 224 (1996) 58-65
28. Mirhashemi R., Averette H.E., Estape R., Angioli R., Mahran R., Mendez L., et al. Low colorectal anastomosis after radical pelvic surgery: a risk factor analysis. Am. J. Obstet. Gynecol. 183 (2000) 1375-1380
29. Graffner H., Fredlund P., Olsson S.A., Oscarson J., and Peterson B.G. Protective colostomy in low anterior resection of the rectum using the EEA stapling instrument: a randomized study. Dis. Colon Rectum 26 (1983) 87-90
30. Berek J.S., Hacker N.F., and Lagasse L.D. Rectosigmoid colectomy and reanastomosis to facilitate resection of primary and recurrent gynecologic cancer. Obstet. Gynecol. 64 (1984) 715-720
31. Hida J., Yasutomi M., Fujimoto K., Okuno K., Ieda S., Machidera N., et al. Functional outcome after low anterior resection with low anastomosis for rectal cancer using the colonic J-pouch: prospective randomized study for determination of optimum pouch size. Dis. Colon Rectum 39 (1996) 986-991
32. Harris G.J.C., Lavery I.C., and Fazio V.W. Function of a colonic J pouch continues to improve with time. Br. J. Surg. 88 (2001) 1623-1627
33. Mantyh C.R., Hull T.L., and Fazio V.W. Coloplasty in low colorectal anastomosis. Dis. Colon Rectum 44 (2001) 37-42
34. Husain A., Curtin J., Brown C., Chi D., Hoskins W., Poynor E., et al. Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies. Gynecol. Oncol. 78 (2000) 208-211
35. Hawighorst-Knapstein S., Schonefussrs G., Hoffmann S.O., and Knapstein P.G. Pelvic exenteration: effects of surgery on quality of life and body image. A prospective longitudinal study. Gynecol. Oncol. 66 (1997) 495-500
36. Berek J.S., Hacker N.F., and Lagasse L.D. Reconstructive pelvic surgery. In: Knapp R.C., and Berkowitz R.S. (Eds). Gynecologic Oncology. 2nd ed. (1993), McGraw-Hill, New York 420-431
37. Berek J.S., Hacker N.F., and Lagasse L.D. Vaginal reconstruction performed simultaneously with pelvic exenteration. Obstet. Gynecol. 63 (1984) 318-323
38. Hatch K.D. Construction of a neovagina after exenteration using the vulvobulbocavernosus myocutaneous graft. Obstet. Gynecol. 63 (1984) 110-114
39. Berek J.S. Surgical techniques. In: Berek J.S., and Hacker N.F. (Eds). Practical Gynecologic Oncology. 4th ed. (2005), Philadelphia' Lippincott Williams and Wilkins 739-782
40. Kaplan E., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
41. Fleisch M.C., Pantke P., Beckmann M.W., Schnuerch H.G., Ackermann R., Grimm M.O., et al. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers. J. Surg. Oncol. 95 (2007) 476-484
42. Park J.Y., Choi H.J., Jeong S.Y., Chung J., Park J.K., and Park S.Y. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: analysis of risk factors predicting recurrence and survival. J. Surg. Oncol. 96 7 (2007 Dec. 1) 560-568
43. Hockel M., Schlenger K., Hamm H., Knapstein P.G., Hohenfellner R., and Rosler H.P. Five-year experience with the combined operative and radiotherapeutic treatment (CORT) of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 77 (1996) 1918-1933
44. Hockel M. Ultra-radical compartmentalized surgery in gynaecological oncology. Eur J. Surg. Oncol. 32 (2006) 859-865
45. Hockel M. Laterally extended endopelvic resection (LEER)-principles and practice. Gynecol. Oncol. 111 2 Suppl. (2008 Nov)
46. Del Carmen M.G., McIntyre J.F., and Goodman A. The role of intraoperative radiation therapy (IORT) in the treatment of locally advanced gynecologic malignancies. The Oncologist 5 (2000) 18-25
47. Miller B., Morris M., Levenback C., Burke T.W., and Gershenson D.M. Pelvic exenteration for primary and recurrent vulvar cancer. Gynecol. Oncol. 58 2 (1995 Aug) 202-205
48. Barber H.R., and Brunschwig A. Treatment and results of recurrent cancer of corpus uteri in patients receiving anterior and total pelvic exenteration 1947-1963. Cancer 22 5 (1968 Nov) 949-955
49. Morris M., Alvarez R.D., Kinney W.K., and Wilson T.O. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol. Oncol. 60 2 (1996 Feb) 288-291
50. Barakat R.R., Goldman N.A., Patel D.A., Venkatraman E.S., and Curtin J.P. Pelvic exenteration for recurrent endometrial cancer. Gynecol. Oncol. 75 1 (1999 Oct) 99-102
51. Barber H.R. Relative prognostic significance of preoperative and operative findings in pelvic exenteration. Surg. Clin. North Am. 49 2 (1969 Apr) 431-447
52. Sharma S., Odunsi K., Driscoll D., and Lele S. Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute. Int. J. Gynecol. Cancer 15 3 (2005 May-Jun) 475-482
53. Husain A., Akhurst T., Larson S., Alektiar K., Barakat R.R., and Chi D.S. A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration. Gynecol. Oncol. 106 1 (2007 Jul) 177-180
54. Pawlik T.M., Skibber J.M., and Rodriguez-Bigas M.A. Pelvic exenteration for advanced pelvic malignancies. Ann. Surg. Oncol. 13 5 (2006 May) 612-623